Generation and Characterization of Conditional Heparin-Binding EGF-Like Growth Factor Knockout Mice

被引:34
|
作者
Oyagi, Atsushi
Oida, Yasuhisa
Kakefuda, Kenichi
Shimazawa, Masamitsu
Shioda, Norifumi
Moriguchi, Shigeki
Kitaichi, Kiyoyuki
Nanba, Daisuke
Yamaguchi, Kazumasa
Furuta, Yasuhide
Fukunaga, Kohji
Higashiyama, Shigeki
Hara, Hideaki
机构
[1] Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Gifu
[2] Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai
[3] Department of Pharmacology, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki
[4] Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime
[5] Nihon Bioresearch Center Inc., Gifu
[6] Department of Biochemistry and Molecular Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
来源
PLOS ONE | 2009年 / 4卷 / 10期
关键词
CENTRAL-NERVOUS-SYSTEM; FACTOR HB-EGF; RAT-BRAIN; SCHIZOPHRENIC-PATIENTS; PREPULSE INHIBITION; ABNORMAL EXPRESSION; DENDRITIC SPINES; TRANSGENIC MICE; CELL-MIGRATION; IN-VIVO;
D O I
10.1371/journal.pone.0007461
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recently, neurotrophic factors and cytokines have been shown to be associated in psychiatric disorders, such as schizophrenia, bipolar disorder, and depression. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the EGF family, serves as a neurotrophic molecular and plays a significant role in the brain. We generated mice in which HB-EGF activity is disrupted specifically in the ventral forebrain. These knockout mice showed (a) behavioral abnormalities similar to those described in psychiatric disorders, which were ameliorated by typical or atypical antipsychotics, (b) altered dopamine and serotonin levels in the brain, (c) decreases in spine density in neurons of the prefrontal cortex, (d) reductions in the protein levels of the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor and post-synaptic protein-95 (PSD-95), (e) decreases in the EGF receptor, and in the calcium/calmodulin-dependent protein kinase II (CaMK II) signal cascade. These results suggest the alterations affecting HB-EGF signaling could comprise a contributing factor in psychiatric disorder.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Heparin-binding EGF-like growth factor
    B B A Biomembr, 3 (F179):
  • [2] Heparin-binding EGF-like growth factor
    Raab, G
    Klagsbrun, M
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (03): : F179 - F199
  • [3] Heparin-binding EGF-like growth factor: a juxtacrine growth factor
    Iwamoto, R
    Mekada, E
    CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (04) : 335 - 344
  • [5] Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor
    Takazaki, R
    Shishido, Y
    Iwamoto, R
    Mekada, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (45) : 47335 - 47343
  • [6] PURIFICATION AND CHARACTERIZATION OF TRANSMEMBRANE FORMS OF HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR
    ONO, M
    RAAB, G
    LAU, K
    ABRAHAM, JA
    KLAGSBRUN, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (49) : 31315 - 31321
  • [7] Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor
    Wang, Xiaobiao
    Mizushima, Hiroto
    Adachi, Satoshi
    Ohishi, Minako
    Iwamoto, Ryo
    Mekada, Eisuke
    CELL STRUCTURE AND FUNCTION, 2006, 31 (01) : 15 - 27
  • [8] Heparin-binding EGF-like growth factor: Hepatotrophic factor in liver regeneration
    Kiso, S
    Tamura, S
    Kawata, S
    TRENDS IN GASTROENTEROLOGY AND HEPATOLOGY: MILLENNIUM 2000, 2001, : 312 - 316
  • [9] A short form of the heparin-binding EGF-like growth factor with a changed EGF domain
    Luk'yanov, EV
    Viedlokha, A
    Kuyavskaya, DV
    Olsnes, S
    Kozlov, YV
    MOLECULAR BIOLOGY, 2002, 36 (01) : 58 - 64
  • [10] A Short Form of the Heparin-binding EGF-like Growth Factor with a Changed EGF Domain
    E. V. Luk'yanov
    A. Viedlokha
    D. V. Kuyavskaya
    S. Olsnes
    Yu. V. Kozlov
    Molecular Biology, 2002, 36 : 58 - 64